Correlation Between Biomarin Pharmaceutical and Legend Biotech
Can any of the company-specific risk be diversified away by investing in both Biomarin Pharmaceutical and Legend Biotech at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Biomarin Pharmaceutical and Legend Biotech into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Biomarin Pharmaceutical and Legend Biotech Corp, you can compare the effects of market volatilities on Biomarin Pharmaceutical and Legend Biotech and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Biomarin Pharmaceutical with a short position of Legend Biotech. Check out your portfolio center. Please also check ongoing floating volatility patterns of Biomarin Pharmaceutical and Legend Biotech.
Diversification Opportunities for Biomarin Pharmaceutical and Legend Biotech
0.08 | Correlation Coefficient |
Significant diversification
The 3 months correlation between Biomarin and Legend is 0.08. Overlapping area represents the amount of risk that can be diversified away by holding Biomarin Pharmaceutical and Legend Biotech Corp in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Legend Biotech Corp and Biomarin Pharmaceutical is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Biomarin Pharmaceutical are associated (or correlated) with Legend Biotech. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Legend Biotech Corp has no effect on the direction of Biomarin Pharmaceutical i.e., Biomarin Pharmaceutical and Legend Biotech go up and down completely randomly.
Pair Corralation between Biomarin Pharmaceutical and Legend Biotech
Given the investment horizon of 90 days Biomarin Pharmaceutical is expected to under-perform the Legend Biotech. But the stock apears to be less risky and, when comparing its historical volatility, Biomarin Pharmaceutical is 1.5 times less risky than Legend Biotech. The stock trades about -0.04 of its potential returns per unit of risk. The Legend Biotech Corp is currently generating about -0.01 of returns per unit of risk over similar time horizon. If you would invest 4,789 in Legend Biotech Corp on November 9, 2024 and sell it today you would lose (1,178) from holding Legend Biotech Corp or give up 24.6% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Insignificant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Biomarin Pharmaceutical vs. Legend Biotech Corp
Performance |
| Timeline |
| Biomarin Pharmaceutical |
| Legend Biotech Corp |
Biomarin Pharmaceutical and Legend Biotech Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Biomarin Pharmaceutical and Legend Biotech
The main advantage of trading using opposite Biomarin Pharmaceutical and Legend Biotech positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Biomarin Pharmaceutical position performs unexpectedly, Legend Biotech can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Legend Biotech will offset losses from the drop in Legend Biotech's long position.| Biomarin Pharmaceutical vs. Alnylam Pharmaceuticals | Biomarin Pharmaceutical vs. Exelixis | Biomarin Pharmaceutical vs. Halozyme Therapeutics | Biomarin Pharmaceutical vs. Arrowhead Pharmaceuticals |
| Legend Biotech vs. Vaxcyte | Legend Biotech vs. Apellis Pharmaceuticals | Legend Biotech vs. Travere Therapeutics | Legend Biotech vs. Akero Therapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Comparator module to compare the composition, asset allocations and performance of any two portfolios in your account.
Other Complementary Tools
| Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Price Ceiling Movement Calculate and plot Price Ceiling Movement for different equity instruments | |
| My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like | |
| Share Portfolio Track or share privately all of your investments from the convenience of any device | |
| Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing |